Drug Profile
MLN 519
Alternative Names: LDP 519; MLN519; PN 05; PS 519Latest Information Update: 29 Jun 2006
Price :
$50
*
At a glance
- Originator Millennium Pharmaceuticals
- Class Anti-inflammatories; Lactones
- Mechanism of Action Immunomodulators; Proteasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation; Reperfusion injury; Stroke